1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia : a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study
(
- Contribution to journal › Article
- 2020
-
Mark
A combined effect of anti-HPA-1a and anti-HLA Class I in pregnancy?
(
- Contribution to journal › Article
-
Mark
The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program
(
- Contribution to journal › Letter
- 2013
-
Mark
Mechanisms and prevention of alloimmunization in pregnancy.
(
- Contribution to journal › Article
- 2012
-
Mark
Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
(
- Contribution to journal › Article
-
Mark
The Development of Severe Neonatal Alloimmune Thrombocytopenia due to Anti-HPA-1a Antibodies Is Correlated to Maternal ABO Genotypes
2012) In Clinical & Developmental Immunology(
- Contribution to journal › Article